The Ugandan Sickle Pan-African Research Consortium Registry: Design, Development, and Lessons

Overview

Journal BMC Med Inform Decis Mak

Publisher Biomed Central

Specialty Medical Informatics

Date 2024 Jul 29

PMID 39075479

Authors

Mike Nsubuga

Henry Mutegeki

Daudi Jjingo

Deogratias Munube

Ruth Namazzi

Robert Opoka

Philip Kasirye

Grace Ndeezi

Heather Hume

Ezekiel Mupere

Grace Kebirungi

Isaac Birungi

Jack Morrice

Mario Jonas

Victoria Nembaware

Ambroise Wonkam

Julie Makani

Sarah Kiguli

Affiliations

Soon will be listed here.

Abstract

Background: Sub-Saharan Africa bears the highest burden of sickle cell disease (SCD) globally with Nigeria, Democratic Republic of Congo, Tanzania, Uganda being the most affected countries. Uganda reports approximately 20,000 SCD births annually, constituting 6.67% of reported global SCD births. Despite this, there is a paucity of comprehensive data on SCD from the African continent. SCD registries offer a promising avenue for conducting prospective studies, elucidating disease severity patterns, and evaluating the intricate interplay of social, environmental, and genetic factors. This paper describes the establishment of the Sickle Pan Africa Research Consortium (SPARCo) Uganda registry, encompassing its design, development, data collection, and key insights learned, aligning with collaborative efforts in Nigeria, Tanzania, and Ghana SPARCo registries.

Methods: The registry was created using pre-existing case report forms harmonized from the SPARCo data dictionary and ontology to fit Uganda clinical needs. The case report forms were developed with SCD data elements of interest including demographics, consent, baseline, clinical, laboratory and others. That data was then parsed into a customized REDCap database, configured to suit the optimized ontologies and support retrieval aggregations and analyses. Patients were enrolled from one national referral and three regional referral hospitals in Uganda.

Results: A nationwide electronic patient-consented registry for SCD was established from four regional hospitals. A total of 5,655 patients were enrolled from Mulago National Referral Hospital (58%), Jinja Regional Referral (14.4%), Mbale Regional Referral (16.9%), and Lira Regional Referral (10.7%) hospitals between June 2022 and October 2023.

Conclusion: Uganda has been able to develop a SCD registry consistent with data from Tanzania, Nigeria and Ghana. Our findings demonstrate that it's feasible to develop longitudinal SCD registries in sub-Saharan Africa. These registries will be crucial for facilitating a range of studies, including the analysis of SCD clinical phenotypes and patient outcomes, newborn screening, and evaluation of hydroxyurea use, among others. This initiative underscores the potential for developing comprehensive disease registries in resource-limited settings, fostering collaborative, data-driven research efforts aimed at addressing the multifaceted challenges of SCD in Africa.

References

Shriner D, Rotimi C . Whole-Genome-Sequence-Based Haplotypes Reveal Single Origin of the Sickle Allele during the Holocene Wet Phase. Am J Hum Genet. 2018; 102(4):547-556. PMC: 5985360. DOI: 10.1016/j.ajhg.2018.02.003. View

. The Sickle Cell Disease Ontology: enabling universal sickle cell-based knowledge representation. Database (Oxford). 2019; 2019. PMC: 6878945. DOI: 10.1093/database/baz118. View

Nsubuga M, Galiwango R, Jjingo D, Mboowa G . Generalizability of machine learning in predicting antimicrobial resistance in E. coli: a multi-country case study in Africa. BMC Genomics. 2024; 25(1):287. PMC: 10946178. DOI: 10.1186/s12864-024-10214-4. View

Mulder N, Nembaware V, Adekile A, Anie K, Inusa B, Brown B . Proceedings of a Sickle Cell Disease Ontology workshop - Towards the first comprehensive ontology for Sickle Cell Disease. Appl Transl Genom. 2016; 9:23-9. PMC: 4911424. DOI: 10.1016/j.atg.2016.03.005. View

Ndeezi G, Kiyaga C, Hernandez A, Munube D, Howard T, Ssewanyana I . Burden of sickle cell trait and disease in the Uganda Sickle Surveillance Study (US3): a cross-sectional study. Lancet Glob Health. 2016; 4(3):e195-200. DOI: 10.1016/S2214-109X(15)00288-0. View

Piel F, Patil A, Howes R, Nyangiri O, Gething P, Dewi M . Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet. 2012; 381(9861):142-51. PMC: 3547249. DOI: 10.1016/S0140-6736(12)61229-X. View

Paintsil V, Amuzu E, Nyanor I, Asafo-Adjei E, Mohammed A, Yawnumah S . Establishing a Sickle Cell Disease Registry in Africa: Experience From the Sickle Pan-African Research Consortium, Kumasi-Ghana. Front Genet. 2022; 13:802355. PMC: 8908904. DOI: 10.3389/fgene.2022.802355. View

Wonkam A, Makani J . Sickle cell disease in Africa: an urgent need for longitudinal cohort studies. Lancet Glob Health. 2019; 7(10):e1310-e1311. PMC: 7255820. DOI: 10.1016/S2214-109X(19)30364-X. View

Nembaware V, Mazandu G, Hotchkiss J, Safari Serufuri J, Kent J, Kengne A . The Sickle Cell Disease Ontology: Enabling Collaborative Research and Co-Designing of New Planetary Health Applications. OMICS. 2020; 24(10):559-567. PMC: 7549008. DOI: 10.1089/omi.2020.0153. View

10.

Nnodu O, Madu A, Chianumba R, Isa H, Olanrewaju I, Osagie S . Establishing a database for sickle cell disease patient mapping and survival tracking: The sickle pan-african research consortium Nigeria example. Front Genet. 2022; 13:1041462. PMC: 9672677. DOI: 10.3389/fgene.2022.1041462. View

11.

Makani J, Cox S, Soka D, Komba A, Oruo J, Mwamtemi H . Mortality in sickle cell anemia in Africa: a prospective cohort study in Tanzania. PLoS One. 2011; 6(2):e14699. PMC: 3040170. DOI: 10.1371/journal.pone.0014699. View

12.

Piel F, Rees D, DeBaun M, Nnodu O, Ranque B, Thompson A . Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission. Lancet Haematol. 2023; 10(8):e633-e686. PMC: 11459696. DOI: 10.1016/S2352-3026(23)00096-0. View

13.

Pasalic D, Reddy J, Edwards T, Pan H, Smith B . Implementing an Electronic Data Capture System to Improve Clinical Workflow in a Large Academic Radiation Oncology Practice. JCO Clin Cancer Inform. 2019; 2:1-12. PMC: 6874007. DOI: 10.1200/CCI.18.00034. View

14.

Giovanni M, Whalen C, Hurt D, Ware-Allen L, Noble K, McCarthy M . African Centers of Excellence in Bioinformatics and Data Intensive Science: Building Capacity for Enhancing Data Intensive Infectious Diseases Research in Africa. J Infect Dis Microbiol. 2023; 1(1). PMC: 10658664. DOI: 10.37191/mapsci-jidm-1(2)-006. View

15.

Weatherall D . Genetic variation and susceptibility to infection: the red cell and malaria. Br J Haematol. 2008; 141(3):276-86. DOI: 10.1111/j.1365-2141.2008.07085.x. View

16.

Wilkinson M, Dumontier M, Aalbersberg I, Appleton G, Axton M, Baak A . The FAIR Guiding Principles for scientific data management and stewardship. Sci Data. 2016; 3:160018. PMC: 4792175. DOI: 10.1038/sdata.2016.18. View

17.

Harris P, Taylor R, Minor B, Elliott V, Fernandez M, ONeal L . The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019; 95:103208. PMC: 7254481. DOI: 10.1016/j.jbi.2019.103208. View

18.

Makani J, Sangeda R, Nnodu O, Nembaware V, Osei-Akoto A, Paintsil V . SickleInAfrica. Lancet Haematol. 2020; 7(2):e98-e99. PMC: 7255817. DOI: 10.1016/S2352-3026(20)30006-5. View

19.

Rees D, Williams T, Gladwin M . Sickle-cell disease. Lancet. 2010; 376(9757):2018-31. DOI: 10.1016/S0140-6736(10)61029-X. View

20.

Wonkam A, Ponde C, Nicholson N, Fieggen K, Ramessar R, Davidson A . The burden of sickle cell disease in Cape Town. S Afr Med J. 2012; 102(9):752-4. DOI: 10.7196/samj.5886. View